J Neurol Surg B Skull Base 2012; 73(03): 168-174
DOI: 10.1055/s-0032-1301403
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Outcome after Translabyrinthine Surgery for Vestibular Schwannomas: Report on 1244 Patients

Jacob Bertram Springborg
1   University Clinic of Neurosurgery, Copenhagen University Hospital, Copenhagen Ø, Denmark
,
Kåre Fugleholm
1   University Clinic of Neurosurgery, Copenhagen University Hospital, Copenhagen Ø, Denmark
,
Lars Poulsgaard
1   University Clinic of Neurosurgery, Copenhagen University Hospital, Copenhagen Ø, Denmark
,
Per Cayé-Thomasen
2   Department of Oto-rhino-laryngology, Head and Neck Surgery, Gentofte University Hospital, Hellerup, Denmark
,
Jens Thomsen
2   Department of Oto-rhino-laryngology, Head and Neck Surgery, Gentofte University Hospital, Hellerup, Denmark
,
Sven-Eric Stangerup
2   Department of Oto-rhino-laryngology, Head and Neck Surgery, Gentofte University Hospital, Hellerup, Denmark
› Author Affiliations
Further Information

Publication History

04 November 2011

13 November 2011

Publication Date:
22 February 2012 (online)

Preview

Abstract

The objective of this article is to study the outcome after translabyrinthine surgery for vestibular schwannomas, with special focus on the facial nerve function. The study design is a case series from a national centralized database and it is set in two University Hospitals in Denmark. Participants were 1244 patients who underwent translabyrinthine surgery during a period of 33 years from 1976 to 2009. Main outcome measures were tumor removal, intraoperative facial nerve preservation, complications, and postoperative facial nerve function. In 84% patients, the tumor was totally resected and in ~85% the nerve was intact during surgery. During 33 years, 12 patients died from complications to surgery and ~14% had cerebrospinal fluid leakage. Before surgery, 74 patients had facial paresis and 46% of these improved after surgery. In patients with normal facial function, overall ~70% had a good outcome (House-Brackmann grade 1 or 2). The chance of a good outcome was related to tumor size with a higher the chance the smaller the tumor, but not to the degree of tumor removal. In ~78% of the patients with facial paresis at discharge the paresis improved over time, in ~42% from a poor to a good function. The translabyrinthine approach is generally efficient in tumor control and with satisfactory facial nerve outcome. With larger tumors the risk of a poor outcome is evident and more data on patients managed with alternative strategies are warranted.